List of bibliographic references
Number of relevant bibliographic references: 19.
Ident. | Authors (with country if any) | Title |
---|
000958 (2018) |
Aaron J. Prussin [États-Unis] ; David Otto Schwake [États-Unis] ; Kaisen Lin [États-Unis] ; Daniel L. Gallagher [États-Unis] ; Lauren Buttling [États-Unis] ; Linsey C. Marr [États-Unis] | Survival of the Enveloped Virus Phi6 in Droplets as a Function of Relative Humidity, Absolute Humidity, and Temperature. |
000C96 (2016) |
Geraldine M. Walsh [Canada] ; Andrew W. Shih [Canada] ; Ziad Solh [Canada] ; Mia Golder [Canada] ; Peter Schubert [Canada] ; Margaret Fearon [Canada] ; William P. Sheffield [Canada] | Blood-Borne Pathogens: A Canadian Blood Services Centre for Innovation Symposium. |
001653 (2010) |
Anjeanette Roberts [États-Unis] ; Elaine W. Lamirande ; Leatrice Vogel ; Benoît Baras ; Geneviève Goossens ; Isabelle Knott ; Jun Chen ; Jerrold M. Ward ; Ventzislav Vassilev ; Kanta Subbarao | Immunogenicity and protective efficacy in mice and hamsters of a β-propiolactone inactivated whole virus SARS-CoV vaccine. |
001684 (2010) |
Lisa M. Casanova [États-Unis] ; Soyoung Jeon ; William A. Rutala ; David J. Weber ; Mark D. Sobsey | Effects of air temperature and relative humidity on coronavirus survival on surfaces. |
001764 (2009) |
Christine Dellanno [États-Unis] ; Quinn Vega ; Diane Boesenberg | The antiviral action of common household disinfectants and antiseptics against murine hepatitis virus, a potential surrogate for SARS coronavirus. |
001B27 (2008) |
Girish J. Kotwal [États-Unis] | Genetic diversity-independent neutralization of pandemic viruses (e.g. HIV), potentially pandemic (e.g. H5N1 strain of influenza) and carcinogenic (e.g. HBV and HCV) viruses and possible agents of bioterrorism (variola) by enveloped virus neutralizing compounds (EVNCs). |
001C50 (2007) |
Guifang Shang [République populaire de Chine] ; Brad J. Biggerstaff ; Baocheng Yang ; Chaopeng Shao ; Albert Farrugia | Theoretically estimated risk of severe acute respiratory syndrome transmission through blood transfusion during an epidemic in Shenzhen, Guangdong, China in 2003. |
002136 (2006) |
Jan Balzarini [Belgique] ; Els Keyaerts ; Leen Vijgen ; Herman Egberink ; Erik De Clercq ; Marc Van Ranst ; Svetlana S. Printsevskaya ; Eugenia N. Olsufyeva ; Svetlana E. Solovieva ; Maria N. Preobrazhenskaya | Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics. |
002146 (2006) |
Hiroaki Kariwa [Japon] ; Nobuhiro Fujii ; Ikuo Takashima | Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions and chemical reagents. |
002197 (2006) |
Miriam E R. Darnell [États-Unis] ; Deborah R. Taylor | Evaluation of inactivation methods for severe acute respiratory syndrome coronavirus in noncellular blood products. |
002385 (2005) |
Song-Le Zhang [République populaire de Chine] ; Li-Juan Ma ; Guang Tian ; Liang-Yan Zhang ; Xue-Ying Zhang ; Xi-Liang Wang | [Conditions for SARS-CoV cultivation and inactivation]. |
002457 (2005) |
Xin-Wei Wang [République populaire de Chine] ; Jin-Song Li ; Min Jin ; Bei Zhen ; Qing-Xin Kong ; Nong Song ; Wen-Jun Xiao ; Jing Yin ; Wei Wei ; Gui-Jie Wang ; Bing-Yin Si ; Bao-Zhong Guo ; Chao Liu ; Guo-Rong Ou ; Min-Nian Wang ; Tong-Yu Fang ; Fu-Huan Chao ; Jun-Wen Li | Study on the resistance of severe acute respiratory syndrome-associated coronavirus. |
002510 (2005) |
H F Rabenau [Allemagne] ; L. Biesert ; T. Schmidt ; G. Bauer ; J. Cinatl ; H W Doerr | SARS-coronavirus (SARS-CoV) and the safety of a solvent/detergent (S/D) treated immunoglobulin preparation. |
002839 (2005) |
D. Pinna [Italie] ; A. Sampson-Johannes ; M. Clementi ; G. Poli ; S. Rossini ; L. Lin ; E. Vicenzi | Amotosalen photochemical inactivation of severe acute respiratory syndrome coronavirus in human platelet concentrates. |
002A67 (2004) |
Martin Enserink ; Lei Du | SARS. China dumps CDC head, probes lab. |
002C09 (2004) |
Yulong Wang [République populaire de Chine] ; Xiaoyu Wu ; Yihua Wang ; Bing Li ; Hao Zhou ; Guiyong Yuan ; Yan Fu ; Yongzhang Luo | Low stability of nucleocapsid protein in SARS virus. |
002C41 (2004) |
Miriam E R. Darnell [États-Unis] ; Kanta Subbarao ; Stephen M. Feinstone ; Deborah R. Taylor | Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV. |
002C42 (2004) |
Hiroaki Kariwa [Japon] ; Nobuhiro Fujii ; Ikuo Takashima | Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions, and chemical reagents. |
002C84 (2004) |
M. Yunoki [Japon] ; T. Urayama ; I. Yamamoto ; S. Abe ; K. Ikuta | Heat sensitivity of a SARS-associated coronavirus introduced into plasma products. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i -k "Virus Inactivation"
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/MedMesh.i \
-Sk "Virus Inactivation" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Checkpoint
|type= indexItem
|index= MedMesh.i
|clé= Virus Inactivation
}}
| This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021 | |